NEW YORK, Sept. 20, 2019 /PRNewswire/ -- Yesse Technologies, Inc. (formerly MouSensor), a New York-headquartered biotechnology company, has been awarded a $750,000 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant. The two-year grant will provide funds to support

SUZHOU, China, Sept. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today released the preliminary data from the Phase I bridging study of the Company's investigational anti-PD-1 monoclonal antibody CS1003 for the first time, in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing.Curamir is incubated through a licensing collabo

SAN FRANCISCO, Sept. 20, 2019 /PRNewswire/ -- Rodan + Fields, LLC (Rodan + Fields), a prestige, dermatology-inspired skincare company, and the leading skincare brand in North America, today announced it is launching in Japan in 2020. This is the brand's first step in expanding into the Asian mark

EDISON, N.J. and NEPTUNE, N.J., Sept. 20, 2019 /PRNewswire/ -- Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, announced today that it has launched the first medically integrated urgent care center with behavioral health in the country, a major part of a compr

SILVER SPRING, Md., Sept. 20, 2019 /PRNewswire/ -- Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving treatments more readily available is one of the top ways we can address this crisis. As we observe Prescription Opioid and Heroin Epidemic Awareness Week, a time when we acknowledge the devastating toll the opioid crisis has inflic

PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with diet and exercise may improve blood sugar (glucose).1 Rybelsus® is the first and

BOSTON, Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announ

SILVER SPRING, Md., Sept. 20, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise. Rybelsus is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States th

QUEENS, N.Y., Sept. 20, 2019 /PRNewswire/ -- Crunch Fitness today announced the late-December 2019 opening of a 19,000 square-foot facility with state-of-the-art equipment and amenities in Queens, New York's Rochdale Village. The club will be located at 166-10 Baisley Blvd., on the second floor of the Ro